$64.49
-0.2-0.31%
At close: -
$64.67
0.180.28%
After Hours: Nov 8, 7:29 PM EDT
AstraZeneca reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of AstraZeneca using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-07-25 | $0.99 | $1.20 | -17.5 % |
Mar 2024 | 2024-04-25 | $1.03 | $1.22 | -15.6 % |
Dec 2023 | 2024-02-08 | $0.73 | $0.79 | -8.23 % |
Sep 2023 | 2023-11-09 | $0.87 | $0.84 | 2.98 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-07-25 | $12.98B | $12.75B | 1.83 % |
Mar 2024 | 2024-04-25 | $12.68B | $11.83B | 7.18 % |
Dec 2023 | 2024-02-08 | $12.02B | $12.09B | -0.55 % |
Sep 2023 | 2023-11-09 | $11.49B | $11.66B | -1.44 % |
AstraZeneca (AZN) is scheduled to report earnings on February 6, 2025. The last reported earnings were for reported on July 25, 2024 for Q2.
The Actual EPS was $0.99, which missed the estimate of $1.20.
The Actual Revenue was $13B, which beat the estimate of $12.8B.
Browse earnings estimates, EPS, and revenue on all stocks.